1. Home
  2. Author
  3. Dreyer C

Dreyer C

References (2)

Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268
Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E
Ref : Liver Cancer , 11 :268 , 2022
Abstract :
PubMedSearch : Harding_2022_Liver.Cancer_11_268
PubMedID: 35949290

Title : Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study - Coriat_2016_Int.J.Nanomedicine_11_6207
Author(s) : Coriat R , Faivre SJ , Mir O , Dreyer C , Ropert S , Bouattour M , Desjardins R , Goldwasser F , Raymond E
Ref : Int J Nanomedicine , 11 :6207 , 2016
Abstract :
PubMedSearch : Coriat_2016_Int.J.Nanomedicine_11_6207
PubMedID: 27920527